Effect of Different Oral Anticoagulants on Cognitive Function in Patients with Atrial Fibrillation: A Bayesian Network Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Apr 26

PMID 38669384

Authors

Wanling Ning

Shiheng Wang

Hanqing Tang

Sichu Wu

Xiaosong Huang

Baiyan Liu

Yilin Mao

Affiliations

Soon will be listed here.

Abstract

Background: Atrial fibrillation (AF) is 1 of the most common types of arrhythmias. At present, the treatment for patients with AF mainly includes oral anticoagulants (OACs). Studies have shown that OACs are associated with cognitive decline in patients with atrial fibrillation; however, there is a lack of relevant evidence. This study used Bayesian network meta-analysis (NMA) to investigate the effects of different oral anticoagulants on cognitive decline in patients with AF.

Methods: We systematically searched for clinical studies on oral anticoagulants in patients with AF in PubMed, Web of Science, Embase, and the Cochrane Library as of July 3, 2023. Cochrane's randomized controlled trial bias risk assessment tool and the Newcastle-Ottawa Scale were used to assess the bias risk of the included studies. The main outcome measure was decreased cognitive functioning.

Results: Ten studies were included, including 2 RCTs and 7 RCSs, including 882,847 patients with AF. Five oral anticoagulants and 2 anticoagulants were included: VKAs (especially warfarin), Dabigatran, Edoxaban, Rivaroxaban, Apixaban, and Aspirin, Clopidogrel. The results of the mesh meta-analysis showed that VKAs were superior to warfarin in reducing the risk of cognitive decline in patients with AF (OR = -1.19, 95% CI (-2.35, -0.06), P < .05) (Table 5). The top 3 drugs in terms of the probability of reducing the incidence of cognitive impairment in patients with AF with different oral anticoagulants were VKAs (87%), rivaroxaban (62.2%), and dabigatran (60.8%).

Conclusion: Based on the results of this study, VKAs may be the best intervention measure for reducing the risk of cognitive decline in patients with AF. Owing to the limitations of this study, more high-quality randomized controlled trials with large sample sizes and multiple centers are required to provide more evidence.

References

Lin J, Li C, Chen Y, Weng C, Chien Y, Wu S . Rhythm Control Better Prevents Dementia than Rate Control Strategies in Patients with Atrial Fibrillation-A Nationwide Cohort Study. J Pers Med. 2022; 12(4). PMC: 9025212. DOI: 10.3390/jpm12040572. View

Yagami T, Ueda K, Asakura K, Sakaeda T, Nakazato H, Kuroda T . Gas6 rescues cortical neurons from amyloid beta protein-induced apoptosis. Neuropharmacology. 2003; 43(8):1289-96. DOI: 10.1016/s0028-3908(02)00333-7. View

Mongkhon P, Naser A, Fanning L, Tse G, Lau W, Wong I . Oral anticoagulants and risk of dementia: A systematic review and meta-analysis of observational studies and randomized controlled trials. Neurosci Biobehav Rev. 2018; 96:1-9. DOI: 10.1016/j.neubiorev.2018.10.025. View

Brundel B, Ai X, Hills M, Kuipers M, Lip G, de Groot N . Atrial fibrillation. Nat Rev Dis Primers. 2022; 8(1):21. DOI: 10.1038/s41572-022-00347-9. View

Ferland G . Vitamin K and the nervous system: an overview of its actions. Adv Nutr. 2012; 3(2):204-12. PMC: 3648721. DOI: 10.3945/an.111.001784. View

Salanti G, Ades A, Ioannidis J . Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2010; 64(2):163-71. DOI: 10.1016/j.jclinepi.2010.03.016. View

Lee Z, Ang E, Lim X, Arain S . Association of Risk of Dementia With Direct Oral Anticoagulants Versus Warfarin Use in Patients With Non-valvular Atrial Fibrillation: A Systematic Review and Meta-analysis. J Cardiovasc Pharmacol. 2020; 77(1):22-31. DOI: 10.1097/FJC.0000000000000925. View

Ferland G . Vitamin K, an emerging nutrient in brain function. Biofactors. 2012; 38(2):151-7. DOI: 10.1002/biof.1004. View

Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G . Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl):160S-198S. DOI: 10.1378/chest.08-0670. View

10.

Cheng W, Liu W, Li B, Li D . Relationship of Anticoagulant Therapy With Cognitive Impairment Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic Review. J Cardiovasc Pharmacol. 2018; 71(6):380-387. DOI: 10.1097/FJC.0000000000000575. View

11.

Jacobs V, May H, Bair T, Crandall B, Cutler M, Day J . Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation. Am J Cardiol. 2016; 118(2):210-4. DOI: 10.1016/j.amjcard.2016.04.039. View

12.

Caramelli B, Yu P, Cardozo F, Magalhaes I, Spera R, Amado D . Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial. BMC Med. 2022; 20(1):374. PMC: 9598018. DOI: 10.1186/s12916-022-02563-2. View

13.

Marotta N, Demeco A, Moggio L, Marinaro C, Pino I, Barletta M . Comparative effectiveness of breathing exercises in patients with chronic obstructive pulmonary disease. Complement Ther Clin Pract. 2020; 41:101260. DOI: 10.1016/j.ctcp.2020.101260. View

14.

Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S . Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014; 6:213-20. PMC: 4064952. DOI: 10.2147/CLEP.S47385. View

15.

Jackson D, Riley R, White I . Multivariate meta-analysis: potential and promise. Stat Med. 2011; 30(20):2481-98. PMC: 3470931. DOI: 10.1002/sim.4172. View

16.

Barber M, Tait R, Scott J, Rumley A, Lowe G, Stott D . Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation. J Thromb Haemost. 2004; 2(11):1873-8. DOI: 10.1111/j.1538-7836.2004.00993.x. View

17.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

18.

Rouse B, Chaimani A, Li T . Network meta-analysis: an introduction for clinicians. Intern Emerg Med. 2016; 12(1):103-111. PMC: 5247317. DOI: 10.1007/s11739-016-1583-7. View

19.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4:1. PMC: 4320440. DOI: 10.1186/2046-4053-4-1. View

20.

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the.... Eur Heart J. 2020; 42(5):373-498. DOI: 10.1093/eurheartj/ehaa612. View